Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis
Dysfunctional Illness-related Cognitions in Individuals With Hypochondriasis and Change Thereof
1 other identifier
interventional
84
1 country
1
Brief Summary
This study will compare the efficacy of cognitive therapy and exposure therapy for treating hypochondriasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jun 2010
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 5, 2010
CompletedFirst Posted
Study publicly available on registry
May 7, 2010
CompletedStudy Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedAugust 6, 2014
August 1, 2014
4.2 years
May 5, 2010
August 5, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hypochondriasis Yale-Brown Obsessive-Compulsive Scale (H-YBOCS)
clinician-rated measure that assesses hypochondriacal obsessions, compulsions and avoidance
3 months
Secondary Outcomes (7)
Illness Attitude Scales (IAS)
3 months
Beck-Depression Inventory II (BDI-II)
3 months
Beck Anxiety Inventory (BAI)
3 months
Brief Symptom Inventory (BSI)
3 months
Scale for the Assessment of Illness Behavior (SAIB)
3 months
- +2 more secondary outcomes
Study Arms (3)
Cognitive Therapy (CT)
EXPERIMENTALThere will be 12 50-minute individual sessions conducted at weekly intervals. Booster sessions will be conducted one, three and six months after treatment. Sessions include psychoeducation, attention training, cognitive restructuring, behavioral experiments, imagery rescripting and relapse prevention.
Exposure Therapy (ET)
EXPERIMENTALThere will be 12 50-minute individual sessions conducted at weekly intervals. Booster sessions will be conducted one, three and six months after treatment. Sessions include change of safety behavior, exposition (in sensu and in vivo), and response prevention.
Waiting List (WL)
NO INTERVENTION12 weeks waiting time
Interventions
weekly 50-minute sessions for 12 weeks
Eligibility Criteria
You may qualify if:
- Meets DSM-IV criteria for hypochondriasis
- German fluency and literacy
- Informed consent
You may not qualify if:
- Major medical illness expected to worsen significantly
- Currently in psychotherapy
- Suicidal tendency
- Clinical diagnosis of alcohol or drug addiction, schizophrenia, schizoaffective disorder or bipolar disorder according to DSM-IV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Goethe Universitylead
- German Research Foundationcollaborator
Study Sites (1)
Department of Clinical Psychology and Psychotherapy of the Wolfgang Goethe University
Frankfurt am Main, Hesse, D-60486, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Florian Weck, PhD
Goethe University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
May 5, 2010
First Posted
May 7, 2010
Study Start
June 1, 2010
Primary Completion
August 1, 2014
Study Completion
August 1, 2014
Last Updated
August 6, 2014
Record last verified: 2014-08